BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24164447)

  • 1. Unraveling the molecular structure of the catalytic domain of matrix metalloproteinase-2 in complex with a triple-helical peptide by means of molecular dynamics simulations.
    Díaz N; Suárez D; Valdés H
    Biochemistry; 2013 Nov; 52(47):8556-69. PubMed ID: 24164447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive simulations of the full-length matrix metalloproteinase-2 enzyme in a prereactive complex with a collagen triple-helical peptide.
    Díaz N; Suárez D
    Biochemistry; 2015 Feb; 54(5):1243-58. PubMed ID: 25600631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations of the active matrix metalloproteinase-2: positioning of the N-terminal fragment and binding of a small peptide substrate.
    Díaz N; Suárez D
    Proteins; 2008 Jul; 72(1):50-61. PubMed ID: 18186480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
    Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
    Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulation study on the interaction of collagen-like peptides with gelatinase-A (MMP-2).
    Azhagiya Singam ER; Rajapandian V; Subramanian V
    Biopolymers; 2014 Jul; 101(7):779-94. PubMed ID: 24374600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative interdomain configurations of the full-length MMP-2 enzyme explored by molecular dynamics simulations.
    Díaz N; Suárez D
    J Phys Chem B; 2012 Mar; 116(9):2677-86. PubMed ID: 22324833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemically modified tetracyclines as inhibitors of MMP-2 matrix metalloproteinase: a molecular and structural study.
    Marcial BL; Sousa SF; Barbosa IL; Dos Santos HF; Ramos MJ
    J Phys Chem B; 2012 Nov; 116(46):13644-54. PubMed ID: 23121406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagenolytic Matrix Metalloproteinase Structure-Function Relationships: Insights From Molecular Dynamics Studies.
    Karabencheva-Christova TG; Christov CZ; Fields GB
    Adv Protein Chem Struct Biol; 2017; 109():1-24. PubMed ID: 28683915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics simulations of matrix metalloproteinase 2: role of the structural metal ions.
    Díaz N; Suarez D
    Biochemistry; 2007 Aug; 46(31):8943-52. PubMed ID: 17616173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-helical peptide analysis of collagenolytic protease activity.
    Lauer-Fields JL; Fields GB
    Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and binding effects in peptide substrate selectivity of matrix metalloproteinase-2: Molecular dynamics and QM/MM calculations.
    Díaz N; Suárez D; Suárez E
    Proteins; 2010 Jan; 78(1):1-11. PubMed ID: 19585658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide hydrolysis catalyzed by matrix metalloproteinase 2: a computational study.
    Díaz N; Suárez D
    J Phys Chem B; 2008 Jul; 112(28):8412-24. PubMed ID: 18570467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
    Lauer-Fields JL; Sritharan T; Stack MS; Nagase H; Fields GB
    J Biol Chem; 2003 May; 278(20):18140-5. PubMed ID: 12642591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains.
    Gioia M; Monaco S; Fasciglione GF; Coletti A; Modesti A; Marini S; Coletta M
    J Mol Biol; 2007 May; 368(4):1101-13. PubMed ID: 17379243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping intermolecular interactions and active site conformations: from human MMP-1 crystal structure to molecular dynamics free energy calculations.
    Nash A; Birch HL; de Leeuw NH
    J Biomol Struct Dyn; 2017 Feb; 35(3):564-573. PubMed ID: 26886688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in silico binding study of the peptide derived from HIV-1 CA-CTD and LysRS as a potential HIV-1 blocking site.
    Na Nakorn P; Treesuwan W; Choowongkomon K; Hannongbua S; Boonyalai N
    J Theor Biol; 2011 Feb; 270(1):88-97. PubMed ID: 21093454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and dynamical properties of a full-length HIV-1 integrase: molecular dynamics simulations.
    Wijitkosoom A; Tonmunphean S; Truong TN; Hannongbua S
    J Biomol Struct Dyn; 2006 Jun; 23(6):613-24. PubMed ID: 16615807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.